THE Executive Director of the National Primary Healthcare Development Agency (NPHCDA), Dr. Faisal Shuaib, said today the Federal Government would receive another batch of 3.92 million doses of the Oxford-AstraZeneca vaccine by end of July.
Shuaib disclosed this at a media briefing in Abuja.
He said recent research from Public Health England revealed that the Indian variant of the COVID-19 also known as the Delta variant B.1.617.2 is 92 percent susceptible to Oxford-AstraZeneca vaccine.
The federal government rolled out the COVID-19 vaccine in the country in February after receiving the first batch of the COVID-19 vaccine from the COVAX Facility.
He said: “We now have information that Nigeria will get 3.92m doses of Oxford-Astrazeneca by end of July or early August.
“As we receive additional information on the exact date, we will provide an update regarding timelines and details.”
“ We are happy to inform Nigerians that the vaccine used in the county can protect against the Indian variant of the COVID-19 that caused high morbidity and mortality in the Asian nation.
“However, it underscores the need for us to ramp up our vaccination to more Nigerians.”
